Broides Arnon, Yang Wenjian, Conley Mary Ellen
Department of Immunology, St. Jude Children's Research Hospital, Memphis, USA.
Clin Immunol. 2006 Feb-Mar;118(2-3):195-200. doi: 10.1016/j.clim.2005.10.007. Epub 2005 Nov 16.
No clear genotype/phenotype correlations have been established in patients with X-linked agammaglobulinemia (XLA). To determine if the specific mutation in Btk might be one of the factors that influences the severity of disease or if polymorphic variants in Tec, a cytoplasmic tyrosine kinase that might substitute for Btk, could contribute to the clinical phenotype, we examined the age at diagnosis, the percentage of peripheral blood B cells and the plasma IgM in a large group of patients with XLA. The results demonstrated that polymorphic variants in Tec were not correlated with phenotypic markers; however, the specific mutation in Btk did influence disease severity. Mutations that conceivably allow the production of some Btk, amino acid substitutions or splice defects that occur at conserved but not invariant sites in the splice consensus sequence were associated with older age at diagnosis, a higher percentage of B cells in the peripheral circulation and higher concentrations of plasma IgM.
在X连锁无丙种球蛋白血症(XLA)患者中,尚未建立明确的基因型/表型相关性。为了确定Btk中的特定突变是否可能是影响疾病严重程度的因素之一,或者Tec(一种可能替代Btk的细胞质酪氨酸激酶)中的多态性变体是否可能导致临床表型,我们在一大群XLA患者中检查了诊断年龄、外周血B细胞百分比和血浆IgM。结果表明,Tec中的多态性变体与表型标志物无关;然而,Btk中的特定突变确实影响疾病严重程度。可能允许产生一些Btk的突变、在剪接共有序列中保守但并非不变位点发生的氨基酸替代或剪接缺陷与诊断时年龄较大、外周循环中B细胞百分比更高以及血浆IgM浓度更高有关。